Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study by Tiago Torres, Jensen Yeung, Vimal H. Prajapati, Simone Ribero, Anna Balato, Angelo Valerio Marzano, Maria João Cruz, Maria João Paiva Lopes, Elizabeth Lazaridou, Jose-Manuel Carrascosa, José Miguel Alvarenga, Pedro Farinha, Bruno Duarte, Monica Munera-Campos, Siddhartha Sood, Brian D. Rankin, Michela Ortoncelli, Stefano Caccavale, Silvia Mariel Ferrucci, Gilberto Pires Rosa, Athina Ioanna Daponte, Gianmarco Silvi, Ketty Peris, Niccolò Gori, Francesca Prignano, Antonio Kolios, Pedro Herranz, Stamatios Gregoriou, Natalia Rompoti, Spyridon Gkalpakiotis, Andrea Chiricozzi

Get full text

Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research? by Annika Gutsche, Pascale Salameh, Samad S. Jahandideh, Mehran Roodsaz, Serkan Kutan, Ali Salehzadeh‐Yazdi, Emek Kocatürk, Stamatios Gregoriou, Simon F. Thomsen, Kanokvalai Kulthanan, Papapit Tuchinda, Joachim Dissemond, Alicja Kasperska‐Zajac, Magdalena Zajac, Mateusz Zamłyński, Martijn vanDoorn, Claudio A. S. Parisi, Jonny G. Peter, Cascia Day, Cathryn McDougall, Michael Makris, Daria Fomina, Elena Kovalkova, Nikolai Streliaev, Gerelma Andrenova, Marina Lebedkina, Maryam Khoskhkui, Mehraneh M. Aliabadi, Andrea Bauer, Lea Kiefer, Melba Muñoz, Karsten Weller, Pavel Kolkhir, Martin Metz

Get full text